Intranasal Insulin and Post-stroke Cognition: A Pilot Study
Sponsor: Wake Forest University Health Sciences
A PHASE2 clinical study on Stroke, this trial is completed. The trial is conducted by Wake Forest University Health Sciences and has accumulated 14 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jun 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jun 2021 [monthly]
Completed PHASE2
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 9 earlier versions
-
May 2020 — Sep 2020 [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Feb 2020 — May 2020 [monthly]
Recruiting PHASE2
-
Jun 2019 — Feb 2020 [monthly]
Recruiting PHASE2
-
Jan 2019 — Jun 2019 [monthly]
Recruiting PHASE2
-
Nov 2018 — Jan 2019 [monthly]
Recruiting PHASE2
-
Aug 2018 — Nov 2018 [monthly]
Recruiting PHASE2
Phase: NA → PHASE2
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .